Cheng Zhu

This inventor holds 27 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 21 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Future Wei Technologies, Inc., Merck Sharp & Dohme LLC. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng Zhu. Retrieved from https://idiyas.com/inventor/cheng-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 2)

% Patents Active = 88.9

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 21 (Patent Applications = 14)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 140(Granted Patents)

Location History:

Scotch Plains, NJ (US) (2010)
Edison, NJ (US) (2010 - 2020)
San Jose, CA (US) (2018 - 2020)
Santa Clara, CA (US) (2021)

Company Filing History:

22 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 3,059

Future Wei Technologies, Inc.

patents

1 out of 67

Merck Sharp & Dohme LLC

patents

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Factor XIa Inhibitors

Antidiabetic Compounds

CGRP Receptor Antagonists

GPR120 Agonists

Database Query

Concurrency Control

Beta 3 Adrenergic Agonists

Cholecystokinin Modulators

Spirolactam Compounds

Cyclopropyl Compounds

Hydroxymethyl Pyrrolidines

Imidazole Carboxamides

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497403 - Factor XIa inhibitors (2025-12-16),

2. 12344616 - Factor XIa inhibitors (2025-07-01),

3. 11151111 - Redistributing table data in a database cluster (2021-10-19),

4. 10864211 - Hydroxy isoxazole compounds useful as GPR120 agonists (2020-12-15),

5. 10740332 - Memory-aware plan negotiation in query concurrency control (2020-08-11),

6. 10519115 - Antidiabetic tricyclic compounds (2019-12-31),

7. 10339137 - System and method for caching and parameterizing IR (2019-07-02),

8. 10214512 - Factor XIA inhibitors (2019-02-26),

9. 10143681 - Factor XIa inhibitors (2018-12-04),

10. 10031940 - System and method for database query (2018-07-24),

11. 10000454 - Antidiabetic tricyclic compounds (2018-06-19),

12. 9932311 - Antidiabetic tricyclic compounds (2018-04-03),

13. 9296750 - Spirolactam CGRP receptor antagonists (2016-03-29),

14. 9227973 - Pyridine CGRP receptor antagonists (2016-01-05),

15. 9227972 - Aliphatic spirolactam CGRP receptor antagonists (2016-01-05),

Title: The Innovative Journey of Cheng Zhu

Introduction: Cheng Zhu, a visionary inventor based in Edison, NJ, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Cheng Zhu's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics, a revolutionary wearable device for monitoring health metrics, and a patented system for optimizing renewable energy sources.

Career Highlights: With a background in electrical engineering, Cheng Zhu has a successful track record of developing innovative solutions for complex technological challenges. He has worked for leading tech companies, where he spearheaded research and development projects that have resulted in multiple patents.

Collaborations: Cheng Zhu is known for his collaborative spirit, having partnered with top researchers and engineers in the industry to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking inventions.

Conclusion: Cheng Zhu's relentless pursuit of innovation and his passion for pushing the boundaries of technology have established him as a respected figure in the world of inventors. His dedication to creating solutions that have a positive impact on society sets him apart as a true pioneer in the field.

Profile summary based on public USPTO records.